Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Pilot Experimental Study of the Neuroprotective Effects of Exosomes in Extremely Low Birth Weight Infants
Sponsor: Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare
Summary
To study the safety and efficacy of intranasal administration of exosomes derived from mesenchymal stromal cells on long-term neurodevelopmental outcome in extremely low birth weight infants born at gestational age 25/0-27/6 weeks.
Key Details
Gender
All
Age Range
1 Day - 3 Days
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2022-10-05
Completion Date
2026-12-28
Last Updated
2022-09-28
Healthy Volunteers
No
Conditions
Interventions
Exosomes derived from mesenchymal stromal cells (MSCs)
Exosomes derived from mesenchymal stromal cells (MSCs) will be administered intranasal in ELBW infants
Locations (1)
Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare
Moscow, Russia